+91 7986995600
seclislabs@gmail.com
Contact Us
Home › Cardiovascular Therapy › VALSCUB 50
Cardiovascular Therapy

VALSCUB 50

Sacubitril 24mg + Valsartan 26mg

Dosage Form Tablets
Packing 5*2*14
MRP ₹3480
Prescribed By Cardiologist, Internal Medicine, Cardiac Surgeon, Geriatrician, General Physician

Quick Facts

Form Tablets
Pack 5*2*14
MRP Rs.3480
Prescribed By Cardiologist, Internal Medicine, Cardiac Surgeon, Geriatrician

Key Benefits

01
ARNI — the most advanced class of heart failure medicine.
02
Proven to significantly reduce mortality and hospitalisations in HFrEF.
03
Addresses cardiac remodelling — slows and reverses heart failure progression.
04
Guidelime-recommended over ACE inhibitors in stable HFrEF.

Mechanism of Action

Sacubitril inhibits neprilysin, increasing levels of beneficial natriuretic peptides that reduce fluid retention, dilate vessels, and reverse cardiac remodelling. Valsartan blocks angiotensin II to lower blood pressure and reduce cardiac load. This ARNI combination is the most advanced heart failure pharmacotherapy.

Indications

Heart failure with reduced ejection fraction (HFrEF), as a replacement for ACE inhibitors or ARBs.

Dosage & Administration

Take as prescribed by your doctor or healthcare professional. Do not self-medicate.

Why VALSCUB 50?

VALSCUB 50 is a starting dose of the most advanced heart failure therapy available — proven to reduce mortality beyond standard ACE inhibitor therapy for patients with reduced ejection fraction.

Interested in franchising VALSCUB 50?

Get exclusive monopoly rights in your territory. WHO-GMP certified. Pan India coverage with dedicated support.

📢

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.

Scroll to Top